Spastic paraparesis: treatment
Evidence-based neurology checklist on spastic paraparesis: treatment: Main drugs Baclofen oral: 5-20mg tid or qid Clonazepam: 0.5-1mg daily Dantrolene: 25-100mg qid Diazepam: 5-20mg tid Gabapentin: 240-360mg daily Tizanidine: 4-36mg daily Main interventional treatments Other drugs Other treatments
Main drugs
- Baclofen oral: 5-20mg tid or qid
- Clonazepam: 0.5-1mg daily
- Dantrolene: 25-100mg qid
- Diazepam: 5-20mg tid
- Gabapentin: 240-360mg daily
- Tizanidine: 4-36mg daily
Main interventional treatments
Other drugs
Other treatments
References
- Thibaut A, Chatelle C, Ziegler E, Bruno MA, Laureys S, Gosseries O. Spasticity after stroke: physiology, assessment and treatment. Brain Inj 2013; 27:1093-1105.
- Chang E, Ghosh N, Yanni D, Lee S, Alexandru D, Mozaffar T. A review of spasticity treatments: pharmacological and interventional approaches. Crit Rev Phys Rehabil Med 2013; 25:11-22.
- Peck J, Urits I, Kassem H, et al. Interventional approaches to pain and spasticity related to cerebral palsy. Psychopharmacol Bull 2020; 50(4 Suppl 1):108-120.
